Connect your AI

Alamar Biosciences ALMR Operating lease liabilities

Operating lease liabilities at other companies

Virtu FinancialVIRT

-$13.67M-1.2%

Avis Budget GroupCAR

-$308M-17.1%

Sherwin-WilliamsSHW

-$118.7M+4.4%

T-Mobile USTMUS

-$1.22B-35.6%

StoneX Group Inc.SNEX

-$3.6M+2.7%

LKQLKQ

-$1M—

Other financials

Income statement

Revenue$26.0M+98.9%

Gross profit$14.5M+126%

Operating income-$12.3M-44.4%

Net income-$21.3M-178%

EPS (diluted)-$1.74-156%

Balance sheet

Cash & equivalents$64.6M—

Total debt$30.6M—

Total equity-$178.1M—

Total assets$186.5M—

Cash flow

Operating cash flow-$20.3M-55.7%

CapEx$600.0K+8.3%

Free cash flow-$20.9M-53.8%

Valuation

Market cap$1.52B—

Enterprise value$1.49B—

Returns & leverage

Debt / equity-0.2×—

Current ratio5.9×—

Where this comes from

Reported directly by Alamar Biosciences in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInOperatingLeaseLiability.

The official record: Alamar Biosciences ’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Alamar Biosciences 's operating lease liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Alamar Biosciences 's operating lease liabilities?: Alamar Biosciences (ALMR) reported operating lease liabilities of -$1.09M in Q1 2026.